In the context of hyperphosphatemia, high phosphate levels, but not activated FGF23/FGFR4 signaling, seem to cause skeletal muscle atrophy, as shown in Col4a3−/− mice [110]. This evidence concerns the gene FGF23 and hyperphosphatemia.